“Guns, taxes and drug companies’ profits may incite or even outrage voters. Drug companies’ profits, though, excite investors.” Today’s article highlights the fact that “profits jumped 17.3% at companies in the pharmaceuticals, biotechnology and life sciences tools and services industries in the Standard & Poor’s 500 last year…faster profit growth than any of the 10 major industry sectors….” But with the drug industry and its profits being the target of heated rhetoric in the presidential campaign (including calls for greater regulation), should investors fear a serious threat to the industry’s continued profit growth? To read what analysts have to say, and to see which drug manufacturers posted the fastest-growing profits in 2015, CLICK HERE.